Cargando…
Antibodies Elicited by an NS1-Based Vaccine Protect Mice against Zika Virus
Zika virus is a mosquito-borne flavivirus which can cause severe disease in humans, including microcephaly and other congenital malformations in newborns and Guillain-Barré syndrome in adults. There are currently no approved prophylactics or therapeutics for Zika virus; the development of a safe and...
Autores principales: | Bailey, Mark J., Broecker, Felix, Duehr, James, Arumemi, Fortuna, Krammer, Florian, Palese, Peter, Tan, Gene S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6445944/ https://www.ncbi.nlm.nih.gov/pubmed/30940710 http://dx.doi.org/10.1128/mBio.02861-18 |
Ejemplares similares
-
Human antibodies targeting Zika virus NS1 provide protection against disease in a mouse model
por: Bailey, Mark J., et al.
Publicado: (2018) -
Zika virus like particles elicit protective antibodies in mice
por: Salvo, Mauricio A., et al.
Publicado: (2018) -
A mosaic hemagglutinin-based influenza virus vaccine candidate protects mice from challenge with divergent H3N2 strains
por: Broecker, Felix, et al.
Publicado: (2019) -
Recombinant Zika virus envelope protein elicited protective immunity against Zika virus in immunocompetent mice
por: Liang, Huabin, et al.
Publicado: (2018) -
Chimeric hemagglutinin split vaccines elicit broadly cross-reactive antibodies and protection against group 2 influenza viruses in mice
por: Puente-Massaguer, Eduard, et al.
Publicado: (2023)